← All diseases

Lysosomal storage diseases

Sandhoff disease

An inherited disease that gradually damages the nerve cells in the brain and spinal cord. It most often begins in infancy. It is very similar to Tay-Sachs disease.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

Orphanet has a guideline for emergency doctors for this disease (language: French). See on Orphanet

Prepare an emergency card

This page is translated from the Turkish original.

This disease is followed through the “Lysosomal storage diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

Two enzymes in the cells, hexosaminidase A and B, do not work well. Because of this, a fatty substance called GM2 cannot be broken down. The substance builds up in the nerve cells. Over time, the nerve cells in the brain and spinal cord are damaged.

Which symptoms can occur?

The most common form begins in infancy. Babies look normal until 3–6 months. There are also very rare, milder forms that begin in childhood or adulthood.

  • Weakness in the muscles
  • Loss of skills such as rolling over, sitting and crawling
  • Being startled too much by loud sounds
  • Seizures (fits)
  • Loss of vision and hearing
  • A cherry-red spot at the back of the eye (seen during an eye examination)
  • Enlarged liver and spleen (sometimes)
  • Problems with speech, balance and movement (in the later forms)

How is it diagnosed?

The doctor looks at the symptoms and the eye examination. The activity of the enzymes hexosaminidase A and B is measured in the blood. The diagnosis is confirmed with a genetic test.

Treatment and care

At present, there is no approved treatment specific to the disease. Care aims to ease the symptoms. Nutrition and fluid support, keeping the airway open and seizure treatment are important. New methods such as gene therapy are being researched. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. Diseases of this kind may be more common in marriages between relatives. Genetic counselling is recommended.

Source: MedlinePlus Genetics: Sandhoff disease · NORD: Sandhoff Disease · Orphanet: Sandhoff disease (ORPHA:796)

Key facts

How is it inherited?
Autosomal recessive
When does it usually start?
Adolescence, Adulthood, Childhood, Infancy

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

For all rare diseases: Nadir Hastalıklar Federasyonu

Links checked on October 8, 2026.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Sandhoff

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

Questions you can ask your doctor

  • Could this trial be suitable for us?
  • If we take part, how would current treatment and check-ups be affected?
  • Where does the trial take place, and how are travel and accommodation handled?
  • What happens if we want to leave the trial?

ClinicalTrials.gov lists 2 active interventional studies for this disease. 1 is recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.

Selected records (studies with a site in Türkiye first):

See all studies on ClinicalTrials.gov · Joining clinical trials

Lysosomal storage diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:796

No separate ICD-11 code; WHO classifies this disease under: 5C56.00

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.